Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Lactobacillus Reuteri Protectis on Functional Abdominal Pain (FAP) in Children 8-14 Years Old

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* FAP (Functional Abdominal Pain) according to Rome III criteria for~* Child/Adolescent (Rasquin, 2006);~* 1 or more abdominal pain episodes per week over the past 8 weeks;~* Informed consent by study participant and at least one parent / legal guardian;~* Age 8-14 years;~* Pain severity at study entry must be at least 40 mm on a 100 mm VAS scale;~* Ability to understand and comply with the requirements of the trial;~* Stated availability throughout the study period.~Exclusion Criteria:~* Chronic illness;~* Surgery of Gastrointestinal tract;~* Any organic symptoms and/or clinical signs of disorder or disease other than FAP;~* Weight loss of 5% or more in body weight over the preceding 3 months;~* Any abnormal result of laboratory assays, also including screening for celiac disease, lactose intolerance;~* Exposure to any drug or medication (antidepressants, SSRIs, laxatives) in the past 3 months or regular use of this medication;~* Exposure to probiotics or antibiotics within 4 weeks prior to study; subjects can be included following a wash-out period of 4 weeks.~* Participation in other clinical trials in the past 3 months;~* Subjects with anemia;~* Subjects with special dietary needs

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- L. reuteri protectis tablets (Type: EXPERIMENTAL): one tablet a day for 4 weeks
- Placebo tablet (Type: PLACEBO_COMPARATOR): one tablet a day for 4 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).